Amprion is a growth-stage diagnostics company that is enabling precision medicine for people with neurodegenerative disorders. Delivering on this goal requires solving hard problems and we need talented, passionate people to help us help patients. 

While we don’t have a list of open opportunities at the moment, we’re in the process of expanding our team and we’d love to hear from you. If you’re ready to join brilliant colleagues to discover what’s next in medicine, now is your moment. 

Please send your resume/CV to

Scientific or commercial experience in dementia, neurodegenerative or movement disorders is a plus.

Our team

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

  • List price of $1500, with courtesy billing for both Medicare and private insurance.
  • An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
  • Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.